血清高尔基体膜蛋白73在原发性肝细胞癌早期诊断中的应用OACSTPCD
Clinical Value of Serum Golgi Protein 73 in Early Diagnosis of Primary Hepatocellular Carcinoma
目的：：探讨原发性肝细胞癌患者血清中高尔基体膜蛋白-73（GP73）的表达水平及其早期诊断价值。方法：选择我院2012年10月—2014年10月门诊、住院患者和健康体检人群，分别用酶联免疫吸附法和化学发光免疫分析法检测63例原发性肝细胞癌、56例肝硬化、87例慢性乙型肝炎、48例其他恶性肿瘤、58例健康对照组血清GP73与甲胎蛋白(AFP)水平，分析两指标各组间差别，绘制其诊断原发性肝细胞癌的ROC 曲线。结果：GP73在不同年龄、性别、肿瘤大小…查看全部>>
Objective To investigate the contents of serum Golgi protein 73(GP73)in patients with pri⁃mary hepatocellular carcinoma (HCC)and to discuss its clinical value in early diagnosis. Methods Six⁃ty-three patients with HCC, 58 patients wiht hepatic cirrhosis, 87 HBV carriers, 48 patients with other malig⁃nant tumors, and 48 healthy control people were involved in this study. GP73 in serum was measured by ELISA and AFP(α-fetoprotein)was measured by ADVIA Centaur X…查看全部>>
李庆芝
山东省菏泽市立医院消化内科 菏泽 274000
医药卫生
高尔基体蛋白73原发性肝细胞癌早期诊断
Golgi protein73primary hepatocellular carcinomaearly diagnosis
《中国中西医结合外科杂志》 2016 (5)
435-437,438,4
评论